Support for Fourth COVID-19 Jab in Blood Cancer Patients

For patients with blood cancer, three doses of COVID-19 vaccine may not generate detectable neutralizing antibodies against the Omicron variant of SARS-CoV-2, according to a new study from the UK.
Reuters Health Information

source https://www.medscape.com/viewarticle/967832?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?